Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged over 18 years
- People who have been diagnosed with cirrhosis (scarring of the liver)
- People who have had an endoscopy (a camera procedure to look inside the digestive tract) showing medium or large swollen veins in the food pipe (esophageal varices)
Who may not be able to join:
- People who have previously had bleeding from swollen veins in the food pipe, or who have already received preventive treatment for those veins
- People who have a blood clot in the portal vein (the main blood vessel supplying the liver), or who have previously had a procedure to redirect blood flow around the liver (such as a TIPS procedure)
- People who are currently taking medications that affect blood pressure in the liver, such as beta blockers or nitrates
- People with serious heart conditions, including recent heart attack, certain heart rhythm problems, heart failure, poor circulation in the limbs, or an abnormally slow heart rate
- People with severe lung conditions such as COPD (chronic obstructive pulmonary disease) or asthma
- People with diabetes that is not well controlled
- People with reduced kidney function
- People who have liver cancer (hepatocellular carcinoma)
- People who have a known allergy to a medication called carvedilol
- People who are pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nabila A Elgazzar, MD, Tropical medicine and infectious diseases Department, Faculty of Medicine, Tanta University
Phone: +201004672358
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Vriceal bleeding rate at 6 weeks follow up; Mortality rate at 6 weeks follow up; Banding side effects at 6 weeks follow up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.